- Home
- ARMN vs FLGT Comparison
ARMN vs FLGT Comparison
Compare ARMN & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMN
- FLGT
- Stock Information
- Founded
- ARMN 1992
- FLGT 2011
- Country
- ARMN Canada
- FLGT United States
- Employees
- ARMN N/A
- FLGT N/A
- Industry
- ARMN
- FLGT Medical Specialities
- Sector
- ARMN
- FLGT Health Care
- Exchange
- ARMN Nasdaq
- FLGT Nasdaq
- Market Cap
- ARMN 775.1M
- FLGT 683.5M
- IPO Year
- ARMN N/A
- FLGT 2016
- Fundamental
- Price
- ARMN $4.18
- FLGT $17.11
- Analyst Decision
- ARMN
- FLGT Hold
- Analyst Count
- ARMN 0
- FLGT 2
- Target Price
- ARMN N/A
- FLGT $28.50
- AVG Volume (30 Days)
- ARMN 479.2K
- FLGT 253.6K
- Earning Date
- ARMN 11-12-2024
- FLGT 11-08-2024
- Dividend Yield
- ARMN N/A
- FLGT N/A
- EPS Growth
- ARMN N/A
- FLGT N/A
- EPS
- ARMN N/A
- FLGT N/A
- Revenue
- ARMN $484,511,000.00
- FLGT $277,761,000.00
- Revenue This Year
- ARMN $46.47
- FLGT N/A
- Revenue Next Year
- ARMN N/A
- FLGT $14.04
- P/E Ratio
- ARMN N/A
- FLGT N/A
- Revenue Growth
- ARMN 13.72
- FLGT N/A
- 52 Week Low
- ARMN $2.60
- FLGT $16.56
- 52 Week High
- ARMN $5.16
- FLGT $30.68
- Technical
- Relative Strength Index (RSI)
- ARMN 44.73
- FLGT 35.11
- Support Level
- ARMN $3.67
- FLGT $16.56
- Resistance Level
- ARMN $4.17
- FLGT $18.61
- Average True Range (ATR)
- ARMN 0.17
- FLGT 1.08
- MACD
- ARMN -0.01
- FLGT -0.33
- Stochastic Oscillator
- ARMN 52.04
- FLGT 12.60
About ARMN Aris Mining Corporation
Aris Mining Corp is engaged in the acquisition, exploration, development and operation of gold properties in Colombia, Guyana and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, Toroparu Project in Guyana and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.